PMID: 9546114Apr 18, 1998Paper

Growth inhibitory and bactericidal activities of lansoprazole compared with those of omeprazole and pantoprazole against Helicobacter pylori

Helicobacter
M Nakao, P Malfertheiner

Abstract

Helicobacter pylori plays a role in the pathogenesis of both duodenal and gastric ulcers. The aim of this study was to evaluate the effect of the proton pump inhibitor (PPI), lansoprazole, commonly used in eradication regimens, on growth, bactericidal activity and morphology of H. pylori in vitro in comparison with other PPIs. Growth inhibitory activity of each of the PPIs was evaluated by determining minimum inhibitory concentrations using an agar dilution method. Bactericidal activity was determined by analysis of the viable cells in culture at various time points after incubation with different concentrations of the PPIs. Bacterial morphology was examined using scanning electron microscopy of fixed cells after exposure to the test substances. Urease activity in cell extracts of H. pylori that had been incubated with increasing concentrations of the PPIs was determined by colorimetry. The growth inhibitory activity of lansoprazole was significantly more potent than that of omeprazole or pantoprazole (MIC90 6.25 vs. 25 and 100 micrograms/ml, respectively). Exposure of H. pylori to lansoprazole produced loss of viability and an aberrant bacterial morphology, which was more extensive than seen with omeprazole or pantoprazole. La...Continue Reading

References

Sep 1, 1992·Infection and Immunity·G I Pérez-PérezM J Blaser
Feb 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·O S Yenen, S Badur
Feb 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S SuerbaumW Opferkuch
Sep 1, 1990·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·T U WestblomB R Midkiff
Sep 1, 1989·Antimicrobial Agents and Chemotherapy·J A García-RodríguezJ L Muñoz Bellido
Aug 1, 1988·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C A McNulty, J C Dent
Jul 1, 1988·The Journal of Antimicrobial Chemotherapy·J W StoneJ Gearty
Jun 1, 1988·European Journal of Epidemiology·Y GlupczynskiA Burette
May 1, 1995·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M NakaoM Uekata
Feb 1, 1995·Alimentary Pharmacology & Therapeutics·L WitzelW Schepp
Sep 1, 1993·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·Y Glupczynski
Sep 1, 1993·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·G von RecklinghausenR Ansorg
Feb 4, 1993·The New England Journal of Medicine·D Y Graham

❮ Previous
Next ❯

Citations

Aug 29, 2009·Digestive Diseases and Sciences·Ramalinga R KedikaStuart Jon Spechler
Oct 14, 2011·Current Gastroenterology Reports·George SachsYi Wen
Apr 30, 2004·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·C Scarpignato
Aug 30, 2000·Clinical Therapeutics·J Horn
Jun 26, 1999·Helicobacter·M TrautmannB Glasbrenner
Dec 22, 1999·Helicobacter·R J AdamekB Pfaffenbach
Feb 2, 2010·Biological & Pharmaceutical Bulletin·Tomoko HanawaShigeru Kamiya
Apr 29, 2011·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Chikako TokoroDaisuke Takahashi
Feb 28, 2014·World Journal of Gastroenterology : WJG·Seung Bae YoonMyung-Gyu Choi
May 17, 2014·World Journal of Gastroenterology : WJG·Jyh-Chin YangChun-Jung Lin
Apr 21, 2004·European Journal of Gastroenterology & Hepatology·Javier P GisbertJosé María Pajares
Feb 16, 2005·Alimentary Pharmacology & Therapeutics·M J R JanssenJ B M J Jansen
Apr 27, 2004·Microbiology and Immunology·Keiji FunatogawaYoshikazu Hirai
May 17, 2006·Alimentary Pharmacology & Therapeutics·C Scarpignato, I Pelosini
Sep 27, 2012·Alimentary Pharmacology & Therapeutics·E A MarcusD R Scott
Feb 5, 2002·Expert Opinion on Pharmacotherapy·D A Gremse
Feb 26, 2014·Brazilian Journal of Anesthesiology·Ismail Aydin ErdenUlkü Aypar
Nov 9, 2016·BMC Medicine·Carmelo ScarpignatoUNKNOWN Italian Society of Pharmacology, the Italian Association of Hospital Gastroenterologists, and the Italian Federation of Gene
Jul 27, 2011·Molekuliarnaia genetika, mikrobiologiia i virusologiia·S V Apal'koA N Glushkov
Aug 11, 2019·Pharmacotherapy·Cynthia T NguyenJulius Li
Apr 19, 2018·Arquivos De Gastroenterologia·Luiz Gonzaga Vaz CoelhoJoaquim Prado de Moraes-Filho
Dec 1, 2015·Allergo Journal International·Eva Untersmayr
Jul 26, 2018·Arquivos De Gastroenterologia·Luiz Gonzaga Vaz CoelhoJosé Vitor Zir
Nov 22, 2020·MMW Fortschritte der Medizin·Manfred GrossPhilip Op den Winkel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.